
NASH NATiV3 Study
Ages
Location
Compensation

NASH Trials in Columbus
Centricity Research is currently participating in the NASH NATiV3 study at our Columbus, Ohio location. NASH (Non-Alcoholic SteatoHepatitis) is the form of liver disease that is triggered by what has come to be known as the “Western diet”, characterized especially by high-fat, high-sugar, and processed foods. Among the effects of a prolonged Western diet is fat accumulation in liver cells (steatosis) which is described as Non-Alcoholic Fatty Liver Disease (NAFLD) and can predispose cells to injury.
NASH NATiV3 Study
The primary objective of the NATiV3 clinical study is to evaluate the long-term effectiveness and safety of an investigational oral drug in the treatment of non-alcoholic steatohepatitis (NASH). You may be eligible to participate if you:
- Are at least 18 years old
- Cannot have known non-NASH liver diseases including:
- Autoimmune diseases
- Drug induced liver disease
- Alcoholic liver disease
- HIV
- Active Hepatitis B or C
We now offer individuals with known risk factors of Non-Alcoholic Fatty Liver Disease (NAFLD) a free Fibroscan screening.
Ready to Volunteer?
Volunteer today to see if you qualify for our NASH NATiV3 clinical research study. Qualified volunteers may be compensated for time and travel.